These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9532050)

  • 1. Pancreas transplantation without antibody therapy.
    Corry RJ; Shapiro R; Egidi MF; Jordan ML; Scantlebury V; Vivas C; Gritsch HA; Starzl TE
    Transplant Proc; 1998 Mar; 30(2):299-300. PubMed ID: 9532050
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Mar; 30(2):507-8. PubMed ID: 9532150
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts.
    Elmer DS; Abdulkarim AB; Fraga D; Shokouh-Amiri H; Stratta RJ; Hathaway DK; Reddy K; Gaber AO
    Transplant Proc; 1998 Mar; 30(2):523-4. PubMed ID: 9532159
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: results of a prospective randomized single-center study.
    Büsing M; Martin D; Schulz T; Heimes M; Klempnauer J; Kozuschek W
    Transplant Proc; 1998 Mar; 30(2):516-7. PubMed ID: 9532155
    [No Abstract]   [Full Text] [Related]  

  • 5. Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients.
    Corry RJ; Egidi MF; Shapiro R; Sugitani A; Gritsch HA; Jordan ML; Dodson SF; Vivas CA; Scantlebury VP; Rao AS; Fung JJ; Starzl TE
    Transplant Proc; 1998 Mar; 30(2):521. PubMed ID: 9532157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive agents in kidney transplantation].
    Nishi S
    Nihon Jinzo Gakkai Shi; 2011; 53(1):1-5. PubMed ID: 21370569
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
    Peddi VR; Demmy AM; Munda R; Alexander JW; First MR
    Transplant Proc; 1998 Mar; 30(2):509-11. PubMed ID: 9532151
    [No Abstract]   [Full Text] [Related]  

  • 8. First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation.
    Kahl A; Bechstein WO; Platz K; Müller A; Berweck S; Venz S; Neuhaus P; Frei U
    Transplant Proc; 1998 Mar; 30(2):505-6. PubMed ID: 9532149
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; West M; Gruessner AC
    Transplant Proc; 1998 Mar; 30(2):518-20. PubMed ID: 9532156
    [No Abstract]   [Full Text] [Related]  

  • 10. Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity.
    Hariharan S; Munda R; Cavallo T; Demmy AM; Schroeder TJ; Alexander JW; First MR
    Transplantation; 1996 Apr; 61(8):1161-5. PubMed ID: 8610411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
    Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits and risks of early antilymphocyte rescue in simultaneous kidney-pancreas transplant recipients.
    Stratta RJ
    Transplant Proc; 1998 Mar; 30(2):525. PubMed ID: 9532160
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation.
    Ciancio G; Burke G; Viciana A; Ruiz P; Roth D; Khan TF; Montane B; Strauss J; Miller J
    Transplant Proc; 1998 Jun; 30(4):1536-7. PubMed ID: 9636624
    [No Abstract]   [Full Text] [Related]  

  • 15. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
    Hanto DW; Chudzinski R
    Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.
    Knight RJ; Kerman RH; Zela S; Podder H; Van Buren CT; Katz S; Kahan BD
    Transplantation; 2003 Apr; 75(8):1301-6. PubMed ID: 12717220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A
    Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.
    Osowski CL; Dix SP; Lin LS; Mullins RE; Geller RB; Wingard JR
    Transplantation; 1996 Apr; 61(8):1268-72. PubMed ID: 8610430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tacrolimus in kidney transplantation. Bürgenstock, Switzerland, 20 March 1998].
    Dtsch Med Wochenschr; 1998 Jul; 123(28-29 Suppl):1-12. PubMed ID: 9697633
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.